Salt Selection & Polymorphism - Crystallics
Crystallics is a science driven contract research organization specializing in the optimization of drug substance physical forms, including salts, polymorphs and amorphous and co-crystals, for the pharmaceutical industry.
Crystallics has developed a number of unique and proprietary technologies both in hardware and software, including proprietary, patented High Throughput X-ray Powder Diffraction (HT-XRPD) technology and laboratory informatics, data analysis and software models. These unique and proprietary technologies, together with strong customer focus, have put Crystallics in the fortunate position to have provided research services, over the last decade, to the vast majority of large and medium size pharmaceutical companies and many smaller biotechnology companies.
Crystallics' value proposition is ‘successful drug development by intelligent solid form selection’.
This value proposition is achieved through:
Tailored approach to meet the needs of the customer and the compound
-
Comprehensive solid state support from lead optimization to late stage development and product life-cycle management
-
Flexibility in screen size, experimental set-up, reporting and business model.
-
Short timelines and transparent communication
Diversity through rational design of experiments
-
Diversity in solvent & counter-ions selection, crystallization modes and conditions and characterization techniques
Proprietary technology & know-how enhancing productivity and ultimately speed to market
-
Uniquely integrated crystallization workflow, patented well plate technology, proprietary XRPD set-up, and other proprietary techniques
-
In-house developed informatics including Aspect and eReporting
-
Smart IP insights and advice
Experienced & knowledged team of scientists
-
100’s of projects over more than 10 year
-
High proportion of repeat business
-
Project leaders are PhDs, crystallographers and/or organic synthetic chemists
Crystallics' research programs are undertaken in close collaboration with the customer. Frequent contacts, effective and timely communication, comprehensive and clear periodic reports, and an electronic report including all raw data ensure optimal information transfer between the project team and the customer before, during and at the end of each program.
For more information please contact us or visit the company website:
Crystallics B.V.
Zekeringstraat 29
1014 BV Amsterdam
The Netherlands
Gunnar Staaf (CEO)
Contact: Gunnar.Staaf@Crystallics.com
Internet: www.crystallics.com
Phone: +31 (0)20 820 2690